Detailed clinical manifestations at onset and prognosis of neonatal-onset Denys–Drash syndrome and congenital nephrotic syndrome of the Finnish type

  • Kentaro Nishi
  • Tomohiro Inoguchi
  • Koichi Kamei
  • Riku Hamada
  • Hiroshi Hataya
  • Masao Ogura
  • Mai Sato
  • Takako Yoshioka
  • Kentaro Ogata
  • Shuichi Ito
  • Koichi Nakanishi
  • Kandai Nozu
  • Yuko Hamasaki
  • Kenji IshikuraEmail author
Original article



Neonatal-onset DenysDrash syndrome (NODDS) is a distinctive clinical entity and has a poor renal and life outcome. Early diagnosis of NODDS is important for managing disorders of sexual development and determining assigned gender. Although patients with NODDS and congenital nephrotic syndrome of the Finnish type (CNF) present with nephrotic syndrome in neonatal life or infancy, the clinical course of NODDS and factors distinguishing these diseases at onset is unknown.


We performed a retrospective cohort study of patients with NODDS and CNF between 1997 and 2017. Patients with nephrotic syndrome and WT1 or NPHS1 mutations with neonatal onset (within 30 days) were eligible.


We studied eight patients with NODDS and 15 with CNF. The median serum creatinine level at onset in the NODDS group was significantly higher (1.85 mg/dL) than that in the CNF group (0.15 mg/dL; P = 0.002). The median placental/fetal weight ratio in the NODDS and CNF group was 41.8% and 21.0%, respectively (P = 0.001). Kaplan–Meier analysis showed that the median number of days for progression to ESRD from onset in the NODDS and CNF groups was 6 and 910 days, respectively (P < 0.001). All patients in the NODDS group were alive at follow-up. Only one patient in the CNF group died of cardiac complications during follow-up.


CNS, renal dysfunction at onset, and a relatively large placenta are prominent signs of NODDS. Prognosis for patients with NODDS is satisfactory if appropriate and active management is performed.


Congenital nephrotic syndrome Congenital nephrotic syndrome of the Finnish type WT1 NPHS1 Neonatal dialysis Disorders of sexual development 



The authors would like to thank Drs. Zentaro Kiuchi, Toshiyuki Nishio, Miwa Goto, and Naoaki Mikami for their academic contribution, and Drs. Yasuyuki Fukuhara, Hironobu Mukaiyama and Ken Saida for genetic advices. We thank Ellen Knapp, PhD, from Edanz Group ( for editing a draft of this manuscript.


There was no external funding for this manuscript. All authors have indicated they have no financial relationships relevant to this article to disclose.

Compliance with ethical standards

Conflict of interest

The authors have no potential conflicts of interest to disclose.

Research involving human participants and/or animals

For this type of study formal consent is not required. This article dose not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent for participating in this study was not required in agreement with the above-mentioned guidelines. For individual gene analysis, informed consent was obtained from all individual participants or their parents.


  1. 1.
    Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol. 2006;21:1653–60.CrossRefGoogle Scholar
  2. 2.
    Davis LM, Zabel B, Senger G, Ludecke HJ, Metzroth B, Call K, Housman D, Claussen U, Horsthemke B, Shows TB. A tumor chromosome rearrangement further defines the 11p13 Wilms tumor locus. Genomics. 1991;10:588–92.CrossRefGoogle Scholar
  3. 3.
    Ohta S, Ozawa T, Shiraga H, Fuse H. Genetic analysis of two female patients with incomplete Denys–Drash syndrome. Endocr J. 2000;47:683–7.CrossRefGoogle Scholar
  4. 4.
    Mueller RF. The Denys–Drash syndrome. J Med Genet. 1994;31:471–7.CrossRefGoogle Scholar
  5. 5.
    Ahn YH, Park EJ, Kang HG, Kim SH, Cho HY, Shin JI, Lee JH, Park YS, Kim KS, Ha IS, Cheong HI. Genotype-phenotype analysis of pediatric patients with WT1 glomerulopathy. Pediatr Nephrol. 2017;32:81–9.CrossRefGoogle Scholar
  6. 6.
    Carter S, Dixit A, Lunn A, Deorukhkar A, Christian M. Renal failure from birth-AKI or CKD? Answers. Pediatr Nephrol. 2016;31:2259–62.CrossRefGoogle Scholar
  7. 7.
    Wang JJ, Mao JH. The etiology of congenital nephrotic syndrome: current status and challenges. World J Pediatr. 2016;12:149–58.CrossRefGoogle Scholar
  8. 8.
    Hutson JM, Grover SR, O'Connell M, Pennell SD. Malformation syndromes associated with disorders of sex development. Nat Rev Endocrinol. 2014;10:476–87.CrossRefGoogle Scholar
  9. 9.
    Lee HJ, Yeom JS, Park JS, Park ES, Seo JH, Lim JY, Park CH, Woo HO, Youn HS. Denys-Drash syndrome, septated vagina and low level of anti-mullerian hormone in male neonate. Ann Pediatr Endocrinol Metab. 2014;19:100–3.CrossRefGoogle Scholar
  10. 10.
    Rheault MN. Nephrotic and nephritic syndrome in the newborn. Clin Perinatol. 2014;41:605–18.CrossRefGoogle Scholar
  11. 11.
    Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac CK, Kashtan CE, Homberg C, Olsen A, Kestila M, Tryggvason K. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet. 1999;64:51–61.CrossRefGoogle Scholar
  12. 12.
    Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet. 1998;62:824–33.CrossRefGoogle Scholar
  13. 13.
    Sako M, Nakanishi K, Obana M, Yata N, Hoshii S, Takahashi S, Wada N, Takahashi Y, Kaku Y, Satomura K, Ikeda M, Honda M, Iijima K, Yoshikawa N. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int. 2005;67:1248–55.CrossRefGoogle Scholar
  14. 14.
    Jalanko H. Congenital nephrotic syndrome. Pediatr Nephrol. 2009;24:2121–8.CrossRefGoogle Scholar
  15. 15.
    Hamasaki Y, Muramatsu M, Hamada R, Ishikura K, Hataya H, Satou H, Honda M, Nakanishi K, Shishido S. Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan. Clin Exp Nephrol. 2017;22:719–26.CrossRefGoogle Scholar
  16. 16.
    Abitbol CL, Seeherunvong W, Galarza MG, Katsoufis C, Francoeur D, Defreitas M, Edwards-Richards A, Raj VMS, Chandar J, Duara S, Yasin S, Zilleruelo G. Neonatal kidney size and function in preterm infants: what is a true estimate of glomerular filtration rate? J Pediatr. 2014;164:1026–31.CrossRefGoogle Scholar
  17. 17.
    Ito S, Takata A, Hataya H, Ikeda M, Kikuchi H, Hata J, Honda M. Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene. J Pediatr. 2001;138:425–7.CrossRefGoogle Scholar
  18. 18.
    Nso Roca AP, Pena Carrion A, Benito Gutierrez M, Garcia Meseguer C, Garcia Pose A, Navarro M. Evolutive study of children with diffuse mesangial sclerosis. Pediatr Nephrol. 2009;24:1013–9.CrossRefGoogle Scholar
  19. 19.
    Hahn H, Cho YM, Park YS, You HW, Cheong HI. Two cases of isolated diffuse mesangial sclerosis with WT1 mutations. J Korean Med Sci. 2006;21:160–4.CrossRefGoogle Scholar
  20. 20.
    Royer-Pokora B, Beier M, Henzler M, Alam R, Schumacher V, Weirich A, Huff V. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A. 2004;127:249–57.CrossRefGoogle Scholar
  21. 21.
    Huttunen NP. Congenital nephrotic syndrome of Finnish type. Study of 75 patients. Arch Dis Child. 1976;51:344–8.CrossRefGoogle Scholar
  22. 22.
    Raaijmakers A, Ortibus E, van Tienoven TP, Vanhole C, Levtchenko E, Allegaert K. Neonatal creatinemia trends as biomarker of subsequent cognitive outcome in extremely low birth weight neonates. Early Hum Dev. 2015;91:367–72.CrossRefGoogle Scholar
  23. 23.
    Brackeen GL, Dover JS, Long CL. Serum albumin. Differences in assay specificity. Nutr Clin Pract. 1989;4:203–5.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2019

Authors and Affiliations

  • Kentaro Nishi
    • 1
  • Tomohiro Inoguchi
    • 2
  • Koichi Kamei
    • 1
  • Riku Hamada
    • 2
  • Hiroshi Hataya
    • 2
  • Masao Ogura
    • 1
  • Mai Sato
    • 1
  • Takako Yoshioka
    • 3
  • Kentaro Ogata
    • 4
  • Shuichi Ito
    • 5
  • Koichi Nakanishi
    • 6
  • Kandai Nozu
    • 7
  • Yuko Hamasaki
    • 2
    • 8
  • Kenji Ishikura
    • 1
    • 9
    Email author
  1. 1.Division of Nephrology and RheumatologyNational Center for Child Health and DevelopmentTokyoJapan
  2. 2.Department of NephrologyTokyo Metropolitan Children’S Medical CenterTokyoJapan
  3. 3.Department of PathologyNational Center for Child Health and DevelopmentTokyoJapan
  4. 4.Department of Pathology, Federation of National Service Personnel Mutual Aid AssociationsTachikawa HospitalTokyoJapan
  5. 5.Department of PediatricsYokohama City University Graduate School of MedicineKanagawaJapan
  6. 6.Department of Child Health and Welfare (Pediatrics), Graduate School of MedicineUniversity of the RyukyusOkinawaJapan
  7. 7.Department of PediatricsKobe University Graduate School of MedicineHyogoJapan
  8. 8.Department of Nephrology, Faculty of MedicineToho UniversityTokyoJapan
  9. 9.Department of PediatricsKitasato University School of MedicineSagamiharaJapan

Personalised recommendations